Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck

Lars Bastholt, Lena Specht, Kenneth Jensen, Eva Brun, Annika Loft, Jørgen Petersen, Helle Kastberg, Jesper G Eriksen

    39 Citations (Scopus)

    Fingerprint

    Dive into the research topics of 'Phase I/II clinical and pharmacokinetic study evaluating a fully human monoclonal antibody against EGFr (HuMax-EGFr) in patients with advanced squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

    Medicine & Life Sciences